OP 2.6 – 00135 Constitutive NKG2A levels and timing of antiretroviral therapy initiation impact the potential role of NK cells after treatment interruption - the pVISCONTI study

• A. Chapel,
• C. Passaes,
• D. Desjardins,
• V. Monceaux,
• A. Melard,
• N. Dereuddre-Bosquet,
• V. Avettand-Fenoel,
• M. Müller-Trutwin,
• R. Le Grand,
• A. Saez-Cirion,
• N. Dimant,
• F. Perdomo-Celis,
• A. David,
• C. Rouzioux

Affiliations

A. Chapel

Institut Pasteur, HIV, Inflammation And Persistence Unit, Université Paris Cité, Paris, France

C. Passaes

Institut Pasteur, HIV, Inflammation And Persistence Unit, Université Paris Cité, Paris, France

D. Desjardins

UMR1184, Immunology of Viral, Auto-Immune, Hematological And Bacterial Diseases (IMVA-HB), IDMIT Department, IBFJ, CEA, Université Paris-Saclay, Inserm, Fontenay-Aux-Roses, le Kremlin-Bicêtre, France

V. Monceaux

Institut Pasteur, HIV, Inflammation And Persistence Unit, Université Paris Cité, Paris, France

A. Melard

Université Paris Cité, INSERM U1016, CNRS UMR 8104, APHP Hôpital Cochin, Paris, France

N. Dereuddre-Bosquet

UMR1184, Immunology of Viral, Auto-Immune, Hematological And Bacterial Diseases (IMVA-HB), IDMIT Department, IBFJ, CEA, Université Paris-Saclay, Inserm, Fontenay-Aux-Roses, le Kremlin-Bicêtre, France

V. Avettand-Fenoel

Université Paris Cité, INSERM U1016, CNRS UMR 8104, APHP Hôpital Cochin, Paris, France

M. Müller-Trutwin

Institut Pasteur, HIV, Inflammation And Persistence Unit, Université Paris Cité, Paris, France

R. Le Grand

UMR1184, Immunology of Viral, Auto-Immune, Hematological And Bacterial Diseases (IMVA-HB), IDMIT Department, IBFJ, CEA, Université Paris-Saclay, Inserm, Fontenay-Aux-Roses, le Kremlin-Bicêtre, France

A. Saez-Cirion

Institut Pasteur, HIV, Inflammation And Persistence Unit, Université Paris Cité, Paris, France

N. Dimant

UMR1184, Immunology of Viral, Auto-Immune, Hematological And Bacterial Diseases (IMVA-HB), IDMIT Department, IBFJ, CEA, Université Paris-Saclay, Inserm, Fontenay-Aux-Roses, le Kremlin-Bicêtre, France

F. Perdomo-Celis

Institut Pasteur, HIV, Inflammation And Persistence Unit, Université Paris Cité, Paris, France

A. David

Institut Pasteur, HIV, Inflammation And Persistence Unit, Université Paris Cité, Paris, France

C. Rouzioux

Université de Paris/CNRS 8104, APHP Hôpital Necker - Enfants Malades, Paris, France